Applications Published 6 December 2000

Published: 25-Jul-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Aqueous agents for combating parasitic insects and acarina in human beings
    Bayer 1056342*

  • Aqueous formulations of parasiticides for skin application
    Bayer 1056343*

  • Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
    Hau, Kee Hung 1056442*

  • Butorphanol sustained release formulations
    Abbott Laboratories 1054443*

  • Stable-shaped particles of crystalline organic compounds
    Savoir, John Claude 1054444*

  • Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent
    Merck Patent 1054445*

  • Anticonvulsant drugs and pharmaceutical compsns thereof
    Yissum Research Development Company of the Hebrew University of Jerusalem 1054446*

  • Use of deprenyl compounds to treat viral infections and reduce tissue damage associated therewith
    Tatton, William G; Borden, Katherine L; Salvato, Maria 1054447*

  • Pharmaceutical combinations containing tramadol
    ASTA Medica 1054448*

  • 20-HETE antagonists and agonists
    MCW Research Foundation 1054449*

  • Farnesyl-protein transferase inhibitors
    International Phytochemistry Research Laboratories 1054550*

  • Bicyclic pyrrole derivatives as MCP-1 inhibitors
    AstraZeneca 1054451*

  • Indole-3-propionic acids, salts and esters thereof used as medicaments
    South Alabama Medical Science Foundation 1054452*

  • Use of epithelones for the treatment of cancer
    Novartis 1054453*

  • Use of macrolide compounds for treating glaucoma
    Fujisawa Pharmaceutical 1054454*

  • Epimorphian compound and its use
    Avmax 1056455*

  • R-Lansoprazole compsns and methods
    Sepracor 1056456*

  • S-Lansoprazole compsns and methods
    Sepracor 1056457*

  • Method for the treatment of pain, including chronic and femal specific pain
    Wake Forest University 1056458*

  • Treatment of HIV infections
    Supergen 1056459*

  • Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
    Jenapharm 1056460*

  • Method and means for treating glomerulonephritis
    Pharmalink 1056461*

  • Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
    Piljac, Tatjana; Piljac, Goran 1056462*

  • Plant extracts and anti-cancer modalities involving the same
    Novogen Research 1056463*

  • L-Ergothinoneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
    Nutramax Laboratories 1056464*

  • Antimicrobial peptides and derived metapeptides
    Harbor-UCLA Research and Education Institute 1056465*

  • TADG-15: an extracellular serine protase overexposed in breast and ovarian carcinomas
    The Board of Trustees of the University of Arkansas 1056466*

  • Method for the treatment of diseases or disorders of the inner ear
    Otogene Aktiengesellschaft 1056467*

  • Method of promoting embryonic stem cell proiferation
    University of Southern California 1056468*

  • Novel peptide copolymer compsns
    Supratek Pharma 1056469*

  • Multi-oligosaccharide glycoconjugate bacterial meningitis vaccine
    Connaught Laboratories 1056470*

  • Treating atopic dermatitis with IGE antagonists
    Tanox 1056471*

  • Specific antibodies against mammary tumour-associated mucin, method for production and use
    Bastert 1056472*

  • Targeted delivery of biologically active media
    Bracco Research 1056473*

  • Affinity markers for human serum albumin
    ConjuChem 1056474*

  • Dendrimeric fullerene derivatives, method of producing the same and their use as neuroprotectors
    Axiva 1056475*

  • Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compsns
    Synsrob 1056476*

  • Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins
    Bioalliance Pharma 1056477*

  • Targeting gene transfer vectors to certain cell types by pseudotyping with viral glycoprotein
    The Regents of the University of Michigan Technology Management 1056476*

  • Devices and methods for destroying microorganisms, in particular by extra-corporeal process
    Ponce, Eric 1056479*

  • Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
    Sae Ham Pharm 1056710*

  • Phenylalanine derivatives as inhibitors of alpha4 integrins
    Celltech Therapeutics 1056714*

  • Process for preparing 2-acetylthio-3-phenyl-propionic acid and the salts thereof
    Zambon Group 1056715*

  • Cyclohexanediole derivatives
    F Hoffmann-La Roche 1056716*

  • Arylphenyl-substituted cyclic ketoenols
    Bayer 1056717*

  • Antiretroviral functionalised aromatic compounds
    Centre National de la Recheche Scientifiques 1056718*

  • Inhibitos of phopholipase enzymes
    Genetic Institute 1056719*

  • Phtalimido arylpiperazines as alpha 1A receptor antagonists useful in the treatment of benign hyperplasia
    Ortho-McNeil Pharmaceuticals 1056720*

  • Bisulfate salt of HIV protease inhibitor
    Bristol-Myers Squibb 1056722*

  • Substituted cycloalkyl-4-oxonicotinic carboxamides; GABA brain receptor ligands
    Neurogen Corp 1056724*

  • Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
    Bayer 1056725*

  • Solid phase synthesis of 1-aminodantoins
    Procter & Gamble 1056726*

  • Soid support synthesis of oxopiperazines
    Procter & Gamble 1056727*

  • Dihydro-benz(1,4)oxazines and tetrahydroquinoxalines
    Aventis Pharma 1056728*

  • N-[(substituted five membered di- or triaza diunsaturated ring) carbonyl]guanidine derivatives for the treatment of ischaemia
    Pfizer 1056729*

  • Benzoate derivatives of diaryl 1,3,4-oxadiazolone
    Bristol-Myers Squibb 1056730*

  • 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
    Agouron Pharmaceuticals 1056732*

  • Histamine H3 receptor ligands
    James Black Foundation 1056733*

  • Substituted alxoxycarbonyl compounds
    Bayer 1056734*

  • Acid labile prodrugs
    Krka, Tovarna 1056737*

  • Process for the preparation of optically enriched (R)- or (S)-albuterol
    Fine Chemicals Corp; Howden, Christopher 1056740*

  • Method for producing dimeric cyclic esters
    Brussels Biotech 1056741*

  • Anti-viral pyrimidine derivatives
    Tularik 1056742*

  • Benzamide derivatives
    Merck Patent 1056743*

  • 6,9-substituted 2-trans-(4-aminocyclohexyl) amino]purines
    Aventis Pharmaceuticals 1056744*

  • Triazolo-pyridazine derivatives as ligands for GABA receptors
    Merck Sharp & Dohme 1056746*

  • Novel triazolo(4,5-D)pyrimidine compounds
    AstraZeneca 1056749*

  • Synthesis agents containing benzyl magnesium halogenides or allyl magnesium halogenides and method for producing the same
    Chemetall 1056750*

  • Boronic compounds
    Commonwealth Scientific and Industrial Research Organisation 1056751*

  • Catalyst activators comprising expanded anions
    The Dow Chemical Company 1056752*

  • Useful method for triflic acid silylation
    Rhodia Chimie 1056753*

  • Phosphate derivatives of diaryl 1,3,4-oxadiazolone
    Bristol-Myers Squibb 1056754*

  • Asymmetric ring-closing metathesis reactions
    Massachusetts Institute of Technology 1056756*

  • Substituted benzoylferrocene anionic photoinitiators
    University of Georgia Research Foundation 1056757*

  • PYRH gene and protein of Streptococcus pneumoniae
    SmithKline Beecham 1056761*

  • Genetic immunisation with nonstructural proteins of hepatitis C virus
    The General Hospital Corp 1056762*

  • DNA replication proteins of Gram-positive bacteria and their use to screen for chemical inhibitors
    The Rockefeller University 1056763*

  • Secreted proteins and polynucleotides encoding them
    Genetics Institute 1056764*

  • Human potassium channel genes
    Icagen 1056765*

  • Novel anti-estrogenic steroids, and associated pharmaceutical compsns and methods of use
    SRI International 1056768*

  • 15-methyl-cyclopropanosteroids and method for the production thereof
    Jenapharm 1056769*

  • Novel disulphides and thiol compounds
    Dovetail Technologies 1056770*

  • Peptides for inhibition of apoptosis and pharmaceutical compounds containing them
    NST Neurosurvival Technologies 1056771*

  • Angiogenesis targeting molecules
    Resolution Pharmaceuticals 1056773*

  • Methods of treatment of diabetes using peptide analogues of insulin
    Neurocrine Biosciences 1056776*

  • Ligand receptors and uses therefor
    Millennium Pharmaceuticals 1056777*

  • Treating and diagnosing macrophage-mediated diseases using FC receptor ligands
    Medarex 1056781*

  • Method for the development of an HIV vaccine
    Rios, Adam 1056838*

  • Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
    Id Pharma; Friedrich-Schiller-Universitaet; Presselt, Norbert 1056839*

  • Trans-somatics with gene transfer into mammary epithelial cells
    Her Majesty in right of Canada, as represented by the Minister of Agriculture and Agri-food 1056840*

  • Methods and compsns using tumour specific soluble Interleukin-2 receptor alpha molecules
    CLI Oncology 1056841*

  • Genetic vaccine vector engineering
    Maxygen 1056842*

  • Therapeutic blocker of ICER synthesis to prevent ICER-mediated inhibition of immune cell activity
    The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services 1056843*

  • Immunological methods to modulate myostatin in vertebrate subjects
    Biostar 1056845*

  • Anti-angiogenic vaccines; substances and methods relating thereto
    Cancer Research Campaign Technology 1056852*

  • Modified ciliary neurotrophic factor, method of making and methods of use
    Regeneron Pharmaceuticals 1056856*

  • Transporter for saccharide-coupled medicaments
    Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts 1056858*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now